Cargando…

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients

BACKGROUND: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries and its prevalence is increasing. As an emerging therapy with a promising efficacy, immunotherapy has been extensively applied in the treatment of solid tumors. In addition, chromatin regulators (CRs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zesi, Yang, Hongxia, Chen, Ziyu, Jing, Chunli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578220/ https://www.ncbi.nlm.nih.gov/pubmed/36253800 http://dx.doi.org/10.1186/s41065-022-00253-w

Ejemplares similares

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer
por: Zhu, Ke, et al.
Publicado: (2022)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
por: Das, Shaoli, et al.
Publicado: (2020)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

Two- and three-dimensional sonographic findings of harlequin ichthyosis: case report and literature review()
por: Liu, Zesi, et al.
Publicado: (2023)

A Case Report of Retroperitoneal Ectopic Pregnancy After in vitro Fertilization-Embryo Transfer and Literature Review
por: Liu, Zesi, et al.
Publicado: (2023)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer
por: Ding, Hao, et al.
Publicado: (2020)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer
por: Wang, Ziwei, et al.
Publicado: (2021)

Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer
por: Wang, Ziwei, et al.
Publicado: (2023)

Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis
por: Chen, Ziyu, et al.
Publicado: (2023)

Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
por: Jiang, Cheng, et al.
Publicado: (2023)

Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Identification and Validation of an m7G-Related lncRNAs Signature for Prognostic Prediction and Immune Function Analysis in Endometrial Cancer
por: Sun, Jiani, et al.
Publicado: (2022)

Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
por: Wang, Hui, et al.
Publicado: (2020)

Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer
por: Wang, Xiufang, et al.
Publicado: (2021)

An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer
por: Yu, Yonghui, et al.
Publicado: (2023)

Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma
por: Xue, Yuanbo, et al.
Publicado: (2020)

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer
por: Lin, Zhiheng, et al.
Publicado: (2022)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
por: Wang, Wei, et al.
Publicado: (2022)

A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
por: Gong, Zetian, et al.
Publicado: (2022)

A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma
por: Yang, Jingze, et al.
Publicado: (2023)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients
por: Tang, Shanshan, et al.
Publicado: (2021)

Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer
por: Yu, Jing, et al.
Publicado: (2022)

Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients
por: Liu, Puyu, et al.
Publicado: (2023)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
por: Wei, Sitian, et al.
Publicado: (2022)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
por: Zhang, Wenshuo, et al.
Publicado: (2022)

Prediction of overall survival and response to immune checkpoint inhibitors: An immune-related signature for gastric cancer
por: Wang, Zheng, et al.
Publicado: (2021)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1tc5n2r6dsk6bfao5bgb90415o